Sign in
Taking people in FinlandPhase 1

Stool transplant and drug-processing enzymes in irritable bowel syndrome or C. difficile

Tests stool transplant effects on drug-processing enzymes in gut conditions.

Key facts

Who runs it
HUS-Yhtymae
Where
Helsinki, FinlandSee the site
Registry title
KF2022#1 trial: The effect of fecal microbiota transplantation on CYP enzyme activities
Status
Recruiting
Phase
Phase 1
People taking part
25 people, planned
Started
5 Jan 2023
Planned end
31 Dec 2025
Type of study
Interventional
Record updated
21 October 2024

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with irritable bowel syndrome or Clostridioides difficile infection. It studies how a stool transplant from a donor (fecal microbiota transplantation) affects liver enzymes that break down drugs (CYP enzymes).

Age
18 years and older
Sex
All sexes

Main reasons for not taking part

  • Healthy volunteers cannot join.

Where in Finland

  • HUS-YhtymaeHelsinki, FinlandTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record

Print a page for my doctor

Data and sources

Registry record
Listed on the EU's official list of trials (CTIS).How to verify a trial in the registry
Plain-language title
Stool transplant and drug-processing enzymes in irritable bowel syndrome or C. difficileGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Record updated
21 October 2024